Adaptive Biotechnologies (ADPT) EPS (Diluted) Growth (1y) (2021 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) EPS (Diluted) Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 36.90% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 13.90% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 28.42% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | -12.34% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 118.87% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 99.97% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 568.14% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 723.10% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 39.75% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 97.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 39.75% |
| Mar 31, 2026 | 35.63% |
| Dec 31, 2025 | 60.95% |
| Sep 30, 2025 | 126.89% |
| Jun 30, 2025 | 46.36% |
| Mar 31, 2025 | 38.68% |
| Dec 31, 2024 | 52.36% |
| Sep 30, 2024 | 37.44% |
| Jun 30, 2024 | 5.25% |
| Mar 31, 2024 | 18.91% |
| Dec 31, 2023 | -70.70% |
| Sep 30, 2023 | -9.69% |
| Jun 30, 2023 | 9.50% |
| Mar 31, 2023 | 9.28% |
| Dec 31, 2022 | 35.53% |
| Sep 30, 2022 | 20.26% |
| Jun 30, 2022 | -4.16% |
| Mar 31, 2022 | -43.08% |
| Dec 31, 2021 | -28.70% |